Toggle menu

EURODEM

Start date:
Historic
End date:
April 2015
Co-ordinated by:
European Society for Emergency Medicine (EuSEM)

The European Dyspnoea survey in the Emergency departments

Aim

Epidemiologic description of patients presenting to the ED with shortness of breath as main complaint.

Trial Design

Prospective multicentre observational study

Local PI

Dr Matt Reed

Consultant and NRS Career Research Fellow in Emergency Medicine

More EMERGE Trials

Assessing tranexamic acid after hyperacute spontaneous intracerebral haemorrhage.

Read more

TICH 2

Tranexamic Acid for Hyperacute Primary IntraCerebral Haemorrhage

Tranexamic acid for the treatment of gastrointestinal haemorrhage: an international randomised, double blind placebo controlled trial

Read more

Halt-It

Tranexamic acid for the treatment of gastrointestinal haemorrhage

Intervention
1. Ambulatory Device, Rocket Pleural vent insertion
2. Standard Treatment, Aspiration +/- chest drain
Primary Outcome Measures
To assess whether use of an ambulatory device (Rocket Pleural Vent) and treatment strategy reduces hospital stay. Total length of stay in hospital up to 30 days post randomisation. Up to 30 days post randomisation.

Read more

RAMPP trial

RAMPP trial - Randomised Controlled Trial: Pleural vent (rocket) V standard care in Primary Spontaneous Pnuemothorax